Sara Vesely to Clinical Trials as Topic
This is a "connection" page, showing publications Sara Vesely has written about Clinical Trials as Topic.
Connection Strength
0.237
-
Rituximab therapy for thrombotic thrombocytopenic purpura: a proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders. J Clin Apher. 2006 Apr; 21(1):49-56.
Score: 0.237